Condition
End Stage Renal Failure With Renal Transplant
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 59/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results67% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 1 (1)
Trial Status
Completed2
Unknown2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03143556Not ApplicableCompleted
Black Star - Magnetic Stent Removal in Transplant Patients
NCT01653847Not ApplicableCompletedPrimary
Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens
NCT01413464Unknown
The Risk of Venous Clotting in Patients After Renal Transplant
NCT01609673Not ApplicableTerminatedPrimary
Study of Everolimus in de Novo Renal Transplant Recipients
NCT01285375Phase 1UnknownPrimary
Safety and Preliminary Efficacy of the Treatment of Kidney Allografts With Curcumin-containing Preservation Solution
Showing all 5 trials